Creative Biolabs-Immuno-oncology

Anti-CLEC12A (clone SC0Z2E-1G6Z1G) SynExpress pB-BF-I4-K Modified CD8+ T cells (CAT#: ITS-1224-CR1928)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CLEC12A (clone SC0Z2E-1G6Z1G). We employs the Retrovirus (pBAD-BFP-IL-4-KpnI) vector components and the SynExpress system of the Exons Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CLEC12A
Clone
SC0Z2E-1G6Z1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
pBAD
Effector Gene
IL-4
Insertion Sites
KpnI
Gene Modification
Knockout
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.91
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving